Neoral C2 monitoring in pediatric liver transplant recipients

被引：30

作者：

Dunn, S ^{[1
]}

Falkenstein, K ^{[1
]}

Cooney, G ^{[1
]}

机构：

[1] Alfred I DuPont Hosp Children, Wilmington, DE USA

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 7-8期

关键词：

D O I：

10.1016/S0041-1345(01)02318-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：3094 / 3095

页数：2

共 8 条

[1] Nof-11: A one-year pediatric randomized double-blind comparison of neoral versus sandimmune in orthotopic liver transplantation [J].

Alvarez, F ;

Atkison, PR ;

Grant, DR ;

Guilbault, N ;

Jones, AB ;

Kim, PSW ;

Kneteman, NM ;

Laurin, L ;

Martin, SR ;

Murphy, GF ;

Paradis, K ;

Shapiro, J ;

Smith, LJ ;

Superina, RA .

TRANSPLANTATION, 2000, 69 (01) :87-92

[2] Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients [J].

Belitsky, P ;

Dunn, S ;

Johnston, A ;

Levy, G .

CLINICAL PHARMACOKINETICS, 2000, 39 (02) :117-125

[3] Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients [J].

Dunn, S ;

Cooney, G ;

Sommerauer, J ;

Lindsay, C ;

McDiarmid, S ;

Wong, RL ;

Chang, CT ;

Smith, HT ;

Choc, MG .

TRANSPLANTATION, 1997, 63 (12) :1762-1767

[4] Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients [J].

Dunn, SP ;

Cooney, GF ;

Kulinsky, A ;

Falkenstein, K ;

Pierson, A ;

Elder, CA ;

Meligeni, J .

TRANSPLANTATION, 1995, 60 (12) :1438-1442

[5]

DUNN SP, 1997, LIVER TRANSPLANT SUR, V3, P1

[6]

DUNN SP, 2000, TRANSPLANT P SA3, V32, P205

[7] Variable oral absorption of cyclosporine - A biopharmaceutical risk factor for chronic renal, allograft rejection [J].

Kahan, BD ;

Welsh, M ;

Schoenberg, L ;

Rutzky, LP ;

Katz, SM ;

Urbauer, DL ;

VanBuren, CT .

TRANSPLANTATION, 1996, 62 (05) :599-606

[8]

Levy GA, 2000, TRANSPLANTATION, V69, pS387

← 1 →